Home > PE Ratio > BROOKS LABORATORIES

BROOKS LABORATORIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of BROOKS LABORATORIES is 277.73.

Share Price ₹172.2Dec 24,2024
Market Cap ₹451.0 Cr
Earnings-TTM₹1.6 CrTTM-Consolidated Results
Price/Earnings277.73xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for BROOKS LABORATORIES
Please provide your vote to see the results
BROOKS LABORATORIES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of BROOKS LABORATORIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of BROOKS LABORATORIES is calculated as :

Current Market Cap [ ₹451.0 Cr] as on Dec 24,2024

(/) Earnings [ ₹1.6 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 277.73x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for BROOKS LABORATORIES , the investors are currently willing to pay 277.73 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BROOKS LABORATORIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of BROOKS LABORATORIES over the last five years.

Historical PE (Price/Earnings) ratio chart of BROOKS LABORATORIES


PE Ratio Performance Analysis for BROOKS LABORATORIES

- BROOKS LABORATORIES 's latest p/e ratio is 277.73x.

- BROOKS LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2021 averaged 0.00x.

- BROOKS LABORATORIES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 4 fiscal years, BROOKS LABORATORIES 's p/e ratio peaked in Mar2024 at 0x.

- BROOKS LABORATORIES 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does BROOKS LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
BROOKS LABORATORIES 1.62277.73451.0
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5039.16436,103.0
CIPLA LTD4,485.2226.58119,196.0
DR REDDYS LABORATORIES LTD5,406.8020.85112,752.0
ZYDUS LIFESCIENCES LTD4,298.9022.5797,041.2
DIVIS LABORATORIES LTD1,836.0083.63153,540.0
MANKIND PHARMA LTD2,124.8656.51120,073.0
TORRENT PHARMACEUTICALS LTD1,802.0063.88115,112.0
LUPIN LTD2,651.9437.3098,925.3
AUROBINDO PHARMA LTD3,598.8320.3773,314.6
ABBOTT INDIA LTD1,284.6647.0860,480.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BROOKS LABORATORIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 20.37x
Max industry PE 277.73x
Median industry PE 39.16x
Average industry PE 63.24x



You may also like the below Video Courses